Neurogene Inc.

NGNE · Pharmaceutical Preparations

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • NGNE · 64135M105 - Common
Company details and SEC sources

CIK 0001404644 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
NGNE on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Pharmaceutical Preparations (Office of Life Sciences)
Business address
535 W 24 Th Street, 5 Th Floor, New York, NY, 10011
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Fiscal year end
31 December
Former names on EDGAR
Neoleukin Therapeutics, Inc. (to 06 Dec 2023), AQUINOX PHARMACEUTICALS, INC (to 12 Aug 2019), AQUINOX PHARMACEUTICALS (USA) INC (to 24 Dec 2013)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .